Have a personal or library account? Click to login
Small Intestinal Bacterial Overgrowth: Diagnosis, Pathophysiology and Treatment Methods Cover

Small Intestinal Bacterial Overgrowth: Diagnosis, Pathophysiology and Treatment Methods

Open Access
|Sep 2021

References

  1. 1. Turnbaugh P, Ley R, Hamady M et al. The Human Microbiome Project. Nature 2007; 449(7164): 804–810.
  2. 2. Han W, Ye Y. A repository of microbial marker genes related to human health and diseases for host phenotype prediction using microbiome data. Pac Symp Biocomput 2019; 24: 236–247.
  3. 3. Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver 2017; 11(2): 196–208.
  4. 4. Chu H, Fox M, Zheng X et al. Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines. Gastroenterol Res Pract 2016; 2016: 1–8.
  5. 5. Di Stefano M, Quigley EMM. The diagnosis of small intestinal bacterial overgrowth: Two steps forward, one step backwards? Neurogastroenterol Motil 2018; 30(11): e13494.
  6. 6. Travis J, Rutland MD, Jack A, DiPalma MD. GI/Liver Secrets 4th Edition. Saunders; 2010.
  7. 7. Isaacs PE, Kim YS. Blind loop syndrome and small bowel bacterial contamination. Clin Gastroenterol 1983; 12(2): 395–414.
  8. 8. Takakura W, Pimentel M. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update. Front Psychiatry 2020; 10(11): 664.
  9. 9. Corazza GR, Menozzi MG, Strocchi A et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990; 98(2): 302–309.
  10. 10. Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial over-growth: a comprehensive review. Gastroenterol Hepatol (NY) 2007; 3(2): 112–122.
  11. 11. Jung KW, Seo M, Cho YH et al. Prevalence of Fructose Malabsorption in Patients With Irritable Bowel Syndrome After Excluding Small Intestinal Bacterial Overgrowth. J Neurogastroenterol Motil 2018; 24(2): 307–316.
  12. 12. Bowe WP, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis – back to the future? Gut Pathogens 2001; 3(1): 1–11.
  13. 13. Salem I, Ramser A, Isham N, Ghannoum MA. The Gut Microbiome as a Major Regulator of the Gut-Skin Axis. Front Microbiol 2018; 9: 1459.
  14. 14. Gajewski P, Szczeklik A. Zespół rozrostu bakteryjnego. In: Interna Szczeklika. Edition 9. Kraków: MP Wydawnictwo; 2018.
  15. 15. Fialho A, Thota P, McCullough AJ, Shen B. Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease. Gastrointestin Liver Dis 2016; 25(2): 159–165.
  16. 16. Siniewicz-Luzeńczyk K, Tkaczyk M. Small intestinal bacterial overgrowth syndrome in children with idiopathic nephritic syndrome treated with immunosuppressive agents. Pediatria i Medycyna Rodzinna 2016; 12(2): 171–176.
  17. 17. Armbrecht U, Lundell L, Lindstedt G, Stockbruegger RW. Causes of malabsorption after total gastrectomy with Roux-en-Y reconstruction. Acta Chir Scand 1988; 154(1): 37–41.
  18. 18. Roland BC, Ciarleglio MM, Clarke JO, Semler JR, Tomakin E, Mullin GE, Pasricha PJ. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth. J Clin Gastroenterol 2015; 49(7): 571–576.
  19. 19. Achufusi TGO, Sharma A, Zamora EA, Manocha D. Small Intestinal Bacterial Overgrowth: Comprehensive Review of Diagnosis, Prevention, and Treatment Methods. Cureus 2020; 12: e8860.
  20. 20. Ahuja A, Ahuja NK. Conventional, Complementary, and Controversial Approaches to Small Intestinal Bacterial Overgrowth. Practical Gastroenterology 2018; 42(10): 60–66.
  21. 21. Barboza JL, Okun MS, Moshiree B. The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease. Expert Opin Pharmacother 2015; 16(16): 2449–2464.
  22. 22. Esposito S, Biscarini A, Federici B et al. Role of Small Intestinal Bacterial Overgrowth (SIBO) and Inflammation in Obese Children. Front Pediatr 2020; 8: 369.
  23. 23. Miazga A, Osiński M, Cichy W et al. Current views on the etiopathogenesis, clinical manifestation, diagnostics, treatment and correlation with other nosological entities of SIBO. Adv Med Sci 2015; 60(1): 118–124.
  24. 24. Walęcik-Kot W. Zespół jelita drażliwego – aktualne zasady diagnostyki i terapii. Medycyna po Dyplomie 2020 [Internet]. Available from: podyplomie.pl/medycyna/34675,zespol-jelita-drazliwego-aktualne-zasady-diagnostyki-i-terapii.
  25. 25. Gasbarrini A, Corazza GR, Gasbarrini G et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 2009; 29(1): 1–49.
  26. 26. Ledochowski M, Ledochowski L. Hydrogen Breath Tests. Akadmed--Verlag Akademie für Ernahrungsmedizin GmbH Salzburg-Innsbruck, Austria 2nd edition; 2011.
  27. 27. Nowak M, Gulbicka P, Grzymisławski M. Wodorowe testy oddechowe jako narzędzie w diagnostyce schorzeń gastroenterologicznych. Forum Zaburzeń Metabolicznych 2015; 6(3): 124–135.
  28. 28. Rao SSC, Bhagatwala J. Small Intestinal Bacterial Overgrowth. Clinical and Translational Gastroenterology 2019; 10: e00078.
  29. 29. Saad RJ, Chey WD. Breath testing for small intestinal bacterial over-growth: maximizing test accuracy. Clin Gastroenterol Hepatol 2014; 12(12): 1964–1972.
  30. 30. Erdogan A, Rao SSC. Small Intestinal Fungal Overgrowth. Curr Gastroenterol Rep 2015; 17(4): 16.
  31. 31. Shah SC, Day LW, Somsouk M, Sewell JL. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2013; 38(8): 925–934.
  32. 32. Magge S, Lembo A. Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome. Gastroenterol Hepatol (N Y) 2012; 8(11): 739–745.
  33. 33. Stolarczyk A. Składniki FODMAP w żywności. Stand Med Pediatr 2015; 12: 235–243.
  34. 34. Logan AC, Venket Rao A, Irani D. Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value. Med Hypotheses 2003; 60(6): 915–923.
  35. 35. Zhong C, Qu C, Wang B, Liang S, Zeng B. Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence. J Clin Gastroenterol 2017; 51(4): 300–311.
  36. 36. Szymczak W, Moszak M, Bogdański P. Żywieniowe wspomaganie leczenia zespołu przerostu flory bakteryjnej jelita cienkiego – nowe koncepcje dietetyczne. Forum Zaburzeń Metabolicznych 2020; 11(1): 1–10.
  37. 37. Chedid V, Dhalla S, Clarke JO et al. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med 2014; 3(3): 16–24.
  38. 38. Gaffar S, Sarker S, Mahfuz M et al. Impact of Small Intestine Bacterial Overgrowth on Response to a Nutritional Intervention in Bangladeshi Children from an Urban Community. The American Journal of Tropical Medicine and Hygiene. 2019; 100(1): 222–225.
  39. 39. Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol 2014; 6: 71–80.
Language: English
Page range: 101 - 116
Published on: Sep 22, 2021
Published by: SAN University
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Patrycja Maliszewska, published by SAN University
This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 License.